Ilaris.com

Ping response time 3ms Excellent ping
Domain provide by markmonitor.com. Domain ID : 14823180_DOMAIN_COM-VRSN
Created : 1999-12-08T07:48:47Z. Expired: 2025-12-08T07:48:46Z (1 Year, 18 Days left)
Host name 45.60.123.251, IP address: 45.60.123.251, location: United States

System updated on 2024/11/19

Keyword Suggestion

Ilaris

Ilaris injection

Ilaris medication

Ilaris j code

Ilaris companion

Ilaris package insert

Ilaris 150 mg

Ilaris novartis

Ilaris side effects

Ilaris cost

Ilaris dosing

Ilaris drug

Ilaris gout

Ilaris canakinumab

Ilaris dsa

Ilaris copay card

Ilaris cost per month

Ilaris pi

Ilaris patient assistance program

Ilaris.com lookup results from whois.markmonitor.com server:

Network

Owner

Technical support

Abuse

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 45.60.123.251

Fetching Web Sites Hosted

Site Inspections

Loading ...

Port Scanner (IP: 45.60.123.251)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 45.60.123.251)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with ilaris.com

Found 0 emails of this domain

Recent Searched Sites

› Redico.com (34 seconds ago) / US

› Blog.pmarca.com (18 seconds ago) / US

› Androidtvsoft.ru (1 mins ago) / RU

› Corearc.org (50 seconds ago) / US

› Mirror-info.ucoz.com (2 seconds ago) / RU

› Capio.com (5 seconds ago) / SE

› Ilaris.com (0 seconds ago) / US

› Hfzccn.com (10 seconds ago) /

› Brownboots.com (11 seconds ago) / US

› Goldseek.com (4 seconds ago) / US

› Tgstt.org (1 mins ago) / DE

› Gaming.dexp.club (3 seconds ago) / RU

› Vitait.com (4 seconds ago) / US

› Goldbroker.com (7 seconds ago) / US

› Go.iag-media.com (14 seconds ago) / US

› Jktank.net (54 seconds ago) / US

› Announcerpersonald.blogspot.com (39 seconds ago) / US

› 21.cl (36 seconds ago) / CA

› Textilevaluechain.com (1 seconds ago) / US

› Bangla.republicworld.com (13 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with ilaris.com on Search Engine

Autoinflammatory Disease Treatment | ILARIS® (canakinumab)

The most common side effects of ILARIS when used for the treatment of TRAPS, HIDS/MKD, and FMF: cold symptoms, upper respiratory tract infection, runny nose, sore throat, nausea, vomiting, and diarrhea (gastroenteritis), and injection site reactions (such …

Ilaris.com

ILARIS® (canakinumab) Cost Support and Resources

ILARIS has not been studied in patients with a positive TB screen, and the safety of ILARIS in individuals with latent TB infection is unknown. Patients testing positive in TB screening should be treated by standard medical practice prior to therapy with ILARIS. All patients should be instructed to seek medical advice if signs, symptoms, or high risk exposure suggestive of TB (eg, …

Ilarishcp.com

ILARIS Companion Support Program | ILARIS® …

Ilarishcp.com

Official Healthcare Professional Site | ILARIS® (canakinumab)

ILARIS (canakinumab) is a recombinant, human anti-human–IL-1β monoclonal antibody and the only IL-1β–specific inhibitor. 1 ILARIS (canakinumab) is proven efficacious in 7 autoinflammatory diseases across Still’s disease and a range of periodic fever syndromes. 1 Additionally, ILARIS (canakinumab) dosing is once monthly in Still’s ...

Ilarishcp.com

LARIS I COMPANION - ILARIS® (canakinumab)

ILARIS Companion provides access to a wide range of . services—all in one place—that can help patients get their prescribed treatment. Dedicated and dependable support for patients throughout their ILARIS ® treatment journey. LARIS I. COMPANION. INDICATIONS. ILARIS ® (canakinumab) is an interleukin-1β blocker indicated for the treatment of the following …

Ilarishcp.com

ILARIS (canakinumab) COMPANION SERVICE REQUEST FORM (SRF ...

ILARIS ® (canakinumab ... e-mail, telephone calls, and text messages at the numbers and addresses provided on this Form for all purposes described in this Patient Authorization. I also agree to be contacted by the Companies and others on its behalf by telephone calls and text messages made by or using automatic telephone dialing machines or artificial or prerecorded …

Ilarishcp.com

Important Safety Information - ILARIS

It is not known if ILARIS is safe and effective when used to treat SJIA in children under 2 years of age or when used to treat CAPS in children under 4 years of age. IMPORTANT SAFETY INFORMATION. ILARIS can cause serious side effects, including increased risk of serious infections. ILARIS can lower the ability of your immune system to fight ...

Ilaris.com

ILARIS is the only FDA-approved

The most common side effects of ILARIS when used for the treatment of CAPS include: cold symptoms, diarrhea, flu (influenza), runny nose, headache, cough, body aches, nausea, vomiting, and diarrhea (gastroenteritis), feeling like you are spinning (vertigo), weight gain, injection site reactions (such as redness, swelling, warmth, or itching), and nausea.

Ilaris.com

Anderson Ilaris - Email, Phone - Chief Operating Officer ...

Find Anderson Ilaris's accurate email address in Adapt.io. Currently working as Chief Operating Officer at Evolua Educação in Sao Paulo, Brazil.

Adapt.io

Preparation and Injection

ILARIS® is conveniently injected under the skin as a single dose of 4 mg/kg (up to a maximum of 300 mg) once every 4 weeks. The simple step-by-step instructions provided will make preparing and injecting ILARIS® easier. Preparing the injection takes about 30 minutes. Your doctor will tell you ®the right dose of ILARIS to use. Your dose:

Sfda.gov.sa

Corporate Medical Policy: Canakinumab (Ilaris

2021-10-01 · canakinumab (Ilaris®) subcutaneous (SC) injection CAPS Body weight >40 kg: 150 mg SC every 8 weeks Body weight ≥15 kg and ≤40 kg: 2 mg/kg SC every 8 weeks; may be increased to 3 mg/kg for those with inadequate response J0638 900 TRAPS, HIDS/MKD, and FMF Body weight ≤40 kg: 2 mg/kg SC every 4 weeks; may be increased to 4 1950

Bluecrossnc.com

Ilaris® (Canakinumab) - Novartis Deutschland

Das Schulungsmaterial ist mit dem „Blaue Hand“ Logo gekennzeichnet und im Risikomanagementplan zu Ilaris beschrieben. Eine kostenfreie Bestellung der Informationsmaterialien ist über das medizinisch-wissenschaftliche Team des Novartis-Infoservices möglich: Telefon: 0911 – 273 12 100 (Mo. – Fr. von 8.00 bis 18.00 Uhr), Telefax: …

Novartis.de

ILARIS 150 mg/ml sol inj - VIDAL

2021-06-29 · Ilaris est indiqué dans le traitement de la maladie de Still active comprenant la maladie de Still de l'adulte (MSA) et l'arthrite juvénile idiopathique systémique (AJIs) chez les patients âgés de 2 ans et plus, qui ont présenté une réponse inadéquate à un précédent traitement par anti-inflammatoires non stéroïdiens (AINS) et par corticoïdes systémiques. …

Vidal.fr

HIGHLIGHTS OF PRESCRIBING INFORMATION

ILARIS is administered every eight weeks as a single dose via subcutaneous injection. 2.3 Preparation for Administration . Using aseptic technique, reconstitute each vial of ILARIS by slowly injecting 1 mL of preservative-free Sterile Water for Injection with a 1 mL syringe and an 18 G x 2” needle. Swirl the vial slowly at an angle of about ...

Accessdata.fda.gov

Alaris Equity Partners Income Trust (AD-UN-T) Quote - The ...

Real-time Price Updates for Alaris Equity Partners Income Trust (AD-UN-T). Charting, Tear Sheets, Press, Price Performance & more.

Theglobeandmail.com

Ilaris® (canakinumab) - Moda Health

2021-08-03 · − Ilaris 150 mg: 2 vials every 28 days B. Max Units (per dose and over time) [HCPCS Unit]: Cryopyrin-Associated Periodic Syndromes: • 150 billable units every 8 weeks (56 days) All other indications: • 300 billable units every 4 weeks (28 days) III. Initial Approval Criteria 1 Coverage is provided in the following conditions: • Patient is up to date with all vaccinations, …

Modahealth.com

ILARIS - Europa

ILARIS Procedural steps taken and scientific information after the authorisation Application number Scope Opinion/ Notification1 issued on Commission Decision Issued2 / amended on Product Information affected3 Summary N/0076 Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) 28/09/2021 PL IB/0073/G This was an …

Ema.europa.eu

Contact Us - Novartis United States of America

Your inquiries will be forwarded to the appropriate department for a timely follow-up. Our Customer Interaction Center can also be reached by phone at: 1-888-NOW-NOVA (1-888-669-6682) Monday - Friday, 8:30 AM - 5:00 PM (ET). Please note all fields with an asterisk (*) are required. * Email. Subject.

Novartis.us

Hvad er Ilaris®? - Find information på ... - medicin.dk

Canakinumab . Anvendelse. Ilaris ® anvendes til. behandling af en gruppe sjældne periodiske febersyndromer. Gruppen omfatter bl.a. kryopyrin-associerede periodiske syndromer (CAPS), kronisk inflammatorisk neurologisk hud- og ledsygdom, familiær kuldeurticaria (nældefeber fremkaldt af kulde), Muckle-Wells syndrom og familiær middelhavsfeber.

Min.medicin.dk

Domains Expiration Date Updated

Site	Provider	Expiration Date
rdvfl.com	godaddy.com	-2 Years, -229 Days
anagocremations.net	godaddy.com	-2 Years, -227 Days
traceno.xyz	namecheap.com	-2 Years, -100 Days
atbayappliance.com	godaddy.com	-1 Years, -88 Days
tremach.com	namecheap.com	-2 Years, -229 Days
azmanco.com	joker.com	2 Years, 129 Days
idyllicocean.com	gmo.jp	251 Days
xytest.com	godaddy.com	198 Days
hswa.org	domains.google.com	-1 Years, -230 Days
myphotokart.com	namecheap.com	-1 Years, -341 Days